Karolinska Institute, Medical Biochemistry and Biophysics

corporate_fareorganization

Karolinska Institute, Medical Biochemistry and Biophysics

- Funding / Projects
  (1)

1 Projects, page 1 of 1

NANOSPRESSO-NL: Local preparation of high-quality, personalized nucleic acid nanomedicines
assignment_turned_inProject2022 - 9999Partners:Universitair Medisch Centrum Utrecht, Divisie Laboratoria, Apotheek en Biomedische Genetica, Universiteit Leiden, Faculteit der Wiskunde en Natuurwetenschappen, Leiden Academic Centre for Drug Research, Karolinska Institute, Medical Biochemistry and Biophysics, Universiteit Twente, Faculty of Science and Technology (TNW), Fysische Scheidingen, Universiteit Twente +15 partners
Universitair Medisch Centrum Utrecht, Divisie Laboratoria, Apotheek en Biomedische Genetica,
Universiteit Leiden, Faculteit der Wiskunde en Natuurwetenschappen, Leiden Academic Centre for Drug Research,
Karolinska Institute, Medical Biochemistry and Biophysics,
Universiteit Twente, Faculty of Science and Technology (TNW), Fysische Scheidingen,
Universiteit Twente,
Universitair Medisch Centrum Utrecht,
Saxion,
Universiteit Twente, Faculty of Behavioural, Management and Social sciences (BMS), Health Technology and Services Research,
SINTEF, (head-office), Health, Medical Technology,
Erasmus Universiteit Rotterdam, Erasmus School of Health Policy & Management ( ESHPM ),
Leiden University,
Universiteit Twente, Faculty of Electrical Engineering, Mathematics and Computer Science (EEMCS), MESA+ Research Institute for Nanotechnology, BIOS Lab-on-a-Chip group,
Universitair Medisch Centrum Utrecht, Wilhelmina Kinderziekenhuis, Laboratorium Klinische Chemie en Haematologie,
Universitair Medisch Centrum Utrecht, Wilhelmina Kinderziekenhuis, Metabole ziekten,
Universitair Medisch Centrum Utrecht,
Universiteit Utrecht, Faculteit Bètawetenschappen, Departement Farmaceutische Wetenschappen, Pharmacoepidemiology & Clinical Pharmacology,
SINTEF,
Karolinska Institute,
Universiteit Utrecht,
Universitair Medisch Centrum Utrecht, Wilhelmina Kinderziekenhuis
Funder: Netherlands Organisation for Scientific Research (NWO) Project Code: NWA.1389.20.096
NANOSPRESSO-NL specifically addresses the current mismatch between personalized therapeutic strategies and industrial centralized large-scale manufacture of medicines. The NANOSPRESSO-NL consortium is convinced that nucleic acid therapeutics are uniquely qualified for production in local hospital pharmacies in response to the needs of the individual patient. By switching towards a fully standardised platform formulation, quality control can be centred around the production process rather than the end product, quite similar to a popular method of decentralized high-quality espresso making.
linkLink to
shareshareShare
codecodeEmbed
Select content type to embed
All Research products
arrow_drop_down
<script type="text/javascript">  </script>
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
more_vert
linkLink to
shareshareShare
codecodeEmbed
Select content type to embed
All Research products
arrow_drop_down
<script type="text/javascript">  </script>
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu

Karolinska Institute, Medical Biochemistry and Biophysics

Karolinska Institute, Medical Biochemistry and Biophysics

1 Projects, page 1 of 1

NANOSPRESSO-NL: Local preparation of high-quality, personalized nucleic acid nanomedicines

Loading